Search

everythinglearnresearchcommunity

for

Search:↓

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Trichoscopy is a reliable method for diagnosing hair and scalp disorders quickly and non-invasively.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.